Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study-Reference-Cited by-同舟云学术

Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study

Published:2011-11-30 Issue:2 Volume:51 Page:254-261
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Cronin-Fenton Deirdre P.,Hellberg Ylva,Lauridsen Kristina L.,Ahern Thomas P.,Garne Jens Peter,Rosenberg Carol,Silliman Rebecca A.,Sørensen Henrik Toft,Lash Timothy L.,Hamilton-Dutoit Stephen

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2011.633556

Reference29 articles.

1. Tamoxifen: Catalyst for the change to targeted therapy

2. Tamoxifen for early breast cancer: an overview of the randomised trials

3. Paraffin section immunocytochemistry and cytosol-based ligand-binding assays for ER and PR detection in breast cancer: the time has come for more objectivity

4. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Spγ in frozen sections or cytosol-based ligand-binding assays

5. Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer Patients;Cancer Epidemiology Biomarkers & Prevention;2020-01-13

2. Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark;BMJ Open;2018-07

3. The effect of 14-3-3ζ expression on tamoxifen resistance and breast cancer recurrence: a Danish population-based study;Breast Cancer Research and Treatment;2017-06-22

4. Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients;PLOS ONE;2017-03-16

5. Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study;Acta Oncologica;2016-04-08